Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EL1Y
|
||||
Former ID |
DNC008890
|
||||
Drug Name |
3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529748] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H11NO3
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)O)C2=NC=C(O2)C3=CC=C(C=C3)O
|
||||
InChI |
1S/C15H11NO3/c17-12-6-4-10(5-7-12)14-9-16-15(19-14)11-2-1-3-13(18)8-11/h1-9,17-18H
|
||||
InChIKey |
QWBAQAYKEITCRE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estradiol 17 beta-dehydrogenase 1 | Target Info | Inhibitor | [529748] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
References | |||||
Ref 529748 | J Med Chem. 2008 Nov 13;51(21):6725-39. Epub 2008 Oct 15.Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1). | ||||
Ref 529748 | J Med Chem. 2008 Nov 13;51(21):6725-39. Epub 2008 Oct 15.Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.